Related Experiment Video
Updated: Sep 9, 2026

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
Published on: November 7, 2018
Emergence of multidrug-resistant Salmonella typhi in rural southern India
P S Rao1, V Rajashekar, G K Varghese
1Department of Microbiology, Kasturba Hospital, Manipal, Karnataka, India.
Abstract:
Multidrug-resistant Salmonella typhi has spread to many parts of India, causing severe therapeutic problems. Of the 305 clinically suspected cases of enteric fever seen at Kasturba Hospital in Manipal, Karnataka between January 1990 and June 1991, Salmonella bacteremia was detected in 134 patients; 102 of these were caused by S. typhi. Eighty (78.4%) of the isolates from S. typhi-infected patients were resistant to conventional antibiotics used in the treatment of typhoid fever (i.e., ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole). No in vitro resistance was observed to ciprofloxacin, norfloxacin, and gentamicin. Major complications were seen in four patients infected by multiresistant S. typhi; three responded well to ciprofloxacin. The fourth patient died of hemorrhage and acute renal failure, even after receiving ciprofloxacin. In addition, less severe complications such as hepatitis and jaundice were observed in 12 other patients. Seventy-six of the multiresistant S. typhi belonged to phage type O biotype II and four were of untypeable Vi strains. The emergence of multidrug-resistant S. typhi has necessitated the use of fluoroquinolones in the therapy for enteric fever.
Insights
Multidrug-resistant Salmonella typhi poses treatment challenges in India. Fluoroquinolones like ciprofloxacin show promise for treating drug-resistant typhoid fever, though severe cases may still be fatal.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Multidrug-resistant Salmonella typhi (MDRST) is a growing public health concern in India.
- Enteric fever, primarily caused by Salmonella typhi, presents significant therapeutic difficulties due to antimicrobial resistance.
Purpose of the Study:
- To investigate the prevalence of multidrug-resistant Salmonella typhi in suspected enteric fever cases.
- To evaluate the in vitro susceptibility of Salmonella typhi isolates to various antibiotics, including fluoroquinolones.
- To assess the clinical outcomes of treating MDRST infections with fluoroquinolones.
Main Methods:
- Retrospective analysis of clinically suspected enteric fever cases at Kasturba Hospital, Manipal, India (January 1990 - June 1991).
- Isolation and antimicrobial susceptibility testing of Salmonella typhi from blood cultures.
- Clinical data review for complications and treatment responses.
Main Results:
- Out of 134 Salmonella bacteremia cases, 102 were Salmonella typhi.
- 78.4% of S. typhi isolates were resistant to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole.
- No in vitro resistance was observed for ciprofloxacin, norfloxacin, and gentamicin.
- Three of four patients with major complications from MDRST responded well to ciprofloxacin; one patient died.
- Hepatitis and jaundice were observed in 12 other patients.
Conclusions:
- The emergence of MDRST necessitates the use of fluoroquinolones in treating drug-resistant typhoid fever.
- Ciprofloxacin demonstrated in vitro efficacy and clinical benefit in most MDRST cases.
- Continued surveillance and development of effective treatment strategies for MDRST are crucial.
More Related Videos
Related Concept Videos
Sources of Food Contamination
Bacterial Gastroenteritis
Cholera
Clinical Significance of Antibiotic Resistance

